Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03973879
Title Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD
Indications

high grade glioma

Therapies

Atezolizumab + PVSRIPO

Age Groups: adult | senior
Covered Countries


No variant requirements are available.